M. Guaraldi

发表

Anthracyclines in non-small-cell lung cancer: do they have a therapeutic role?

A. Martoni, M. Guaraldi, E. Piana, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study.

A. Paccagnella, A. Bonetti, L. Tomio, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Controlled clinical study on the use of dichloromethylene diphosphonate in patients with breast carcinoma metastasizing to the skeleton.

F. Pannuti, A. Martoni, M. Guaraldi, 1991, Oncology.

Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II–III trial

R. Orecchia, A. Paccagnella, C. Casanova, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Concomitant chemoradiation (CRT) or cetuximab/RT (CET/RT) versus induction Docetaxel/ Cisplatin/5-Fluorouracil (TPF) followed by CRT or CET/RT in patients with Locally Advanced Squamous Cell Carcinoma of Head and Neck (LASCCHN). A randomized phase III factorial study (NCT01086826).

I. Floriani, A. Paccagnella, G. Azzarello, 2014 .

Comparative phase II study of idarubicin versus doxorubicin in advanced breast cancer.

F. Pannuti, A. Martoni, A. Farris, 1990, Oncology.

Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer.

F. Sperandi, B. Melotti, F. Artioli, 2005, European journal of cancer.

A phase II study on lonidamine combined with cisplatin and etoposide in the treatment of advanced non-small cell bronchogenic carcinoma (NSCBC).

F. Pannuti, M. Guaraldi, G. Lelli, 1990, Journal of chemotherapy.

Short report: 5-Fluorouracil + folinic acid with cisplatinum and bleomyein in the treatment of advanced head and neck squamous cell carcinoma

F. Pannuti, A. Martoni, U. Caliceti, 1991 .

Combined chemo-immuno-hormonotherapy of advanced renal cell carcinoma.

F. Pannuti, S. Tamberi, A. Martoni, 1994, Journal of chemotherapy.

An open randomised cross-over study on granisetron versus ondansetron in the prevention of acute emesis induced by moderate dose cisplatin-containing regimens.

F. Pannuti, A. Martoni, E. Strocchi, 1996, European journal of cancer.

Idarubicin metabolism and pharmacokinetics after intravenous and oral administration in cancer patients: a crossover study

F. Pannuti, C. Efthymiopoulos, A. Martoni, 2004, Cancer Chemotherapy and Pharmacology.

Cetuximab/radiotherapy (CET+RT) versus concomitant chemoradiotherapy (cCHT+RT) with or without induction docetaxel/cisplatin/5-fluorouracil (TPF) in locally advanced head and neck squamous cell carcinoma (LASCCHN): Preliminary results on toxicity of a randomized, 2x2 factorial, phase II-III study (N

L. Crinò, I. Floriani, A. Paccagnella, 2012 .

Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer.

F. Pannuti, G. Ferrara, G. Ambrosini, 1998, Lung cancer.

Randomized clinical trial with a weekly regimen of 5-FU vs 5-FU + intermediate-dose folinic acid in the treatment of advanced colo-rectal cancer.

F. Pannuti, A. Martoni, A. Farris, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II study of sequential treatment of advanced non-small-cell lung cancer: three cycles of high-dose epirubicin plus cisplatin followed by weekly vinorelbine.

F. Pannuti, A. Martoni, A. Marino, 2001, Clinical lung cancer.

Activity of high-dose epirubicin in advanced non-small cell lung cancer.

F. Pannuti, B. Melotti, A Martoni, 1991, European journal of cancer.

Combination Chemotherapy With Mitoxantrone, Methotrexate, and Mitomycin (MMM Regimen) in Malignant Pleural Mesothelioma: A Phase II Study

F. Pannuti, C. Pinto, B. Melotti, 2001, American journal of clinical oncology.

Folinic acid plus 5-FU based chemotherapy in squamous cell carcinoma of the head and neck: Bologna experience.

F. Pannuti, B. Melotti, A. Martoni, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

High-dose epirubicin for untreated patients with advanced tumours: a phase I study.

F. Pannuti, A. Riva, B. Melotti, 1990, European journal of cancer.

Prospective Phase II Study of Single-Agent Gemcitabine in Untreated Elderly Patients With Stage IIIB/IV Non–Small-Cell Lung Cancer

G. Robustelli della Cuna, F. Artioli, F. Di Fabio, 2001, American journal of clinical oncology.

A phase II study of high-dose epirubicin plus cisplatinum in advanced non-small-cell lung cancer (NSCLC).

F. Pannuti, A. Martoni, M. Guaraldi, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Planned sequence of gemcitabine followed by vinorelbine in the treatment of elderly patients with advanced non-small cell lung cancer.

B. Melotti, F. Di Fabio, A. Martoni, 2006, Anticancer research.

Treatment of advanced head and neck tumors with PEV-B regimen: a pilot study.

F. Pannuti, A. Martoni, U. Caliceti, 1988, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy.

A phase II-III study comparing concomitant chemoradiotherapy (CRT) versus cetuximab/RT (CET/RT) with or without induction docetaxel/cisplatin/5-fluorouracil (TPF) in locally advanced head and neck squamous cell carcinoma (LASCCHN): Efficacy results (NCT01086826).

L. Crinò, I. Floriani, A. Paccagnella, 2013 .